Notice: This company has been marked as potentially delisted and may not be actively trading. Juno Therapeutics (JUNO) News Today Add Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of DirectorsJanuary 30, 2025 | markets.businessinsider.comEterna Therapeutics Announces Expansion of Scientific Advisory BoardJanuary 28, 2025 | markets.businessinsider.comEterna Therapeutics expands scientific board with oncology expertsJanuary 28, 2025 | msn.comSeattle biotech company raises the first local 9-figure round of 2025January 13, 2025 | bizjournals.comSeattle biotech startup Tune Therapeutics lands $175M to support clinical researchJanuary 13, 2025 | msn.comCAR-T Cell Therapy Market Research 2024-2025: Navigating the CAR-T Landscape, Major Players, Recent Approvals, and Pioneering TherapiesJanuary 3, 2025 | finance.yahoo.comCell therapy company Indapta extends cash runway with $22.5 million roundDecember 23, 2024 | bizjournals.comBorealis Biosciences Appoints Christian Hordo as CEO and Expands Series A FinancingDecember 19, 2024 | finance.yahoo.comIn Her Own Words: Blythe Sather's unscientific path to breakthrough researchNovember 22, 2024 | bizjournals.comShape Therapeutics CEO departs, interim namedOctober 23, 2024 | bizjournals.comHealthcare Venture Investors Ante Up. Public Markets Remain Cool.September 27, 2024 | msn.comEyconis, Inc. Announces Appointment of Dr. Mark J. Bachleda as Chief Executive Officer and Member of the Board of DirectorsSeptember 19, 2024 | finance.yahoo.comNate Hardy to Join Arsenal Biosciences, Inc. as Chief Financial OfficerSeptember 16, 2024 | finance.yahoo.comCara Delevingne’s 2 Sisters: All About Chloe and Poppy DelevingneSeptember 4, 2024 | msn.comCaribou Biosciences, Inc.: Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical OfficerAugust 13, 2024 | finanznachrichten.deSana CEO outlines growth plans after opening Bothell facilityAugust 7, 2024 | bizjournals.comZelda Williams did extensive 'academic study' of '80s films before helming 'Lisa Frankenstein'April 9, 2024 | yahoo.comMichigan AP names Trey McKenney of Orchard Lake St. Mary's Division 1 basketball Player of the YearMarch 30, 2024 | msn.comXcell Biosciences Announces New Scientific and Business Advisory BoardMarch 27, 2024 | finance.yahoo.comOut of the lab and into the factoryMarch 18, 2024 | bizjournals.comEFTR eFFECTOR Therapeutics, Inc.March 16, 2024 | seekingalpha.comMotorcyclist killed in fatal accident near Manatee Avenue, Bradenton police sayMarch 15, 2024 | msn.comWhat we know about Jeff Bezos’ net worthFebruary 21, 2024 | msn.comMantle Cell Lymphoma Therapeutics Market to Reach $3.29 Billion by 2028 with Innovations in Targeted TherapiesFebruary 8, 2024 | uk.finance.yahoo.comZelda Williams Says She Was 'Fascinated’ by Late Dad Robin Williams' Career from Young AgeJanuary 31, 2024 | ca.news.yahoo.comHow Zelda Williams Found Humor in TraumaJanuary 31, 2024 | msn.comCovid cases in Stoke-on-Trent right now as 'Juno' strain hits UKJanuary 16, 2024 | msn.comVaginitis Therapeutics Global Market Landscape Analysis 2023-2030: New Treatment Avenues and Key Company Innovations Propel the IndustryJanuary 11, 2024 | uk.finance.yahoo.comAutolus Therapeutics announces the appointment of Robert W. Azelby to its Board of DirectorsJanuary 10, 2024 | finance.yahoo.comBiotech Industry Veterans Jeff Jonas and Al Robichaud Join Cure Ventures as PartnersJanuary 8, 2024 | tmcnet.comWeek In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4BJanuary 7, 2024 | seekingalpha.comTwo dead in McDermot Avenue fire, cause under investigationDecember 22, 2023 | msn.comElliot Page: Juno actor to divorce Emma PortnerDecember 12, 2023 | bbc.comFirst Patient Enrolled in the PUERTA Phase 2A ARDS Clinical Trial: Treatment with Aqualung Therapeutics ALT-100 mAbDecember 5, 2023 | finance.yahoo.comSeattle Children's launches BrainChild Bio to accelerate CAR T-cell therapies for children with brain tumorsDecember 5, 2023 | finance.yahoo.comTScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D., as Chief Technology OfficerDecember 4, 2023 | markets.businessinsider.comRepairon Appoints Co-Founder Dr. Lothar Germeroth as Chief Executive OfficerSeptember 15, 2023 | tmcnet.comCARGO Therapeutics Announces Appointment of Michael Ports, PhD, as Chief Scientific OfficerSeptember 12, 2023 | finance.yahoo.comNotch Therapeutics closes Vancouver lab, will focus on Toronto and Seattle officesAugust 28, 2023 | msn.comAffini-T Therapeutics shutting down Seattle labJuly 20, 2023 | msn.comADC Therapeutics Announces Evolution of Board of DirectorsJune 15, 2023 | finance.yahoo.comElliot Page writes about relationship with ‘Juno’ co-star Olivia Thirlby in his new memoirJune 15, 2023 | yahoo.comSpeed Read: Elliot Page on Secret ‘Juno’ Hookups, Double Dates With Leonardo DiCaprio and Transphobic ViolenceJune 14, 2023 | yahoo.comElliot Page on Juno, Hollywood’s dark side and coming out twice: ‘Living my life was more important than being in movies’June 14, 2023 | theguardian.comCancer-fighting biotech startup Indapta lands $30M with assist from FDAMay 18, 2023 | bizjournals.com2030, Multiple Myeloma Therapeutics Market: Trend & OutlookMay 13, 2023 | marketwatch.comChinook Therapeutics, Inc.: Chinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate UpdatesMay 10, 2023 | finanznachrichten.de2023-2031 "CAR T-Cell Therapy Market" Development: Key Players Analysis and Innovative Growth OpportunitiesMay 10, 2023 | marketwatch.com2023-2030 Multiple Myeloma Therapeutics Market Size (Growth and Outlook) includes Sales Channel and Regional Analysis | with [101 Pages]May 5, 2023 | marketwatch.comCAR T-Cell Therapy Market Share and Forecast till 2030May 5, 2023 | marketwatch.com Get Juno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter. Email Address JUNO Media Mentions By Week JUNO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JUNO News Sentiment▼0.001.05▲Average News Sentiment JUNO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JUNO Articles This Week▼00▲JUNO Articles Average Week Get Juno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JUNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JUNO) was last updated on 3/1/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredDiscover the Key to a Resilient Investment PortfolioThese 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredWall Street Legend: Crash coming in March—details hereStocks to Crash on March 16, 2026? Here's Compelling Reason Why Perhaps no one on or off Wall Street has be...Chaikin Analytics | SponsoredEx-CIA Officer Reveals Shocking 2025 Warning I don't know if Biden is evil and doing this on purpose or if he's senile and someone else is pulling the str...American Alternative | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredTrump's Head-Spinning First Month Is Over, Here's What to Expect NextTrump's Head-Spinning First Month Is Over. Here's What to Expect Next for Social Security, Taxes and Stocks...Altimetry | Sponsored401K Savers Taking Advantage of “Tariffs” With Odd, 2-Word MoveYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Juno Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Juno Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JUNO Stock Alerts